EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

发布时间:2012-04 来源:journal of hepatology

EASL–EORTC Clinical Practice Guidelines (CPG) on the manage- ment of hepatocellular carcinoma (HCC) define the use of surveil- lance, diagnosis, and therapeutic strategies recommended for patients with this type of cancer. These guidelines update the recommendations reported by the EASL panel of experts in HCC published in 2001 [1]. Several clinical and scien- tific advances have occurred during the past decade and, thus, a modern version of the document is urgently needed. The purpose of this document is to assist physicians, patients, health-care providers, and health-policy makers from Europe and worldwide in the decision-making process according to evidence- based data.

The clinical practice guidelines below will give advice for up to date management of patients with HCC as well as providing an in-depth review of all the relevant data leading to the conclusions.

原文链接:https://www-ncbi-nlm-nih-gov.sw.lib.csmu.edu.tw/pubmed/?term=Journal+of+Hepatology+2012+vol.+56+j+908–943

L.CN.MKT.SM.10.2016.0903

获取全文请填写您的电子邮箱地址,以便我们把文章发送到您的邮箱。

您确认发送到此邮箱。

敬请留意:如您使用126/163邮箱接收下载文献,可能出现延迟或文件丢失问题,温馨提示您使用其他地址,感谢您的关注!

免责声明

关闭